EP2415748A4 - Neue entzündungshemmende verbindungen - Google Patents
Neue entzündungshemmende verbindungenInfo
- Publication number
- EP2415748A4 EP2415748A4 EP10743831.9A EP10743831A EP2415748A4 EP 2415748 A4 EP2415748 A4 EP 2415748A4 EP 10743831 A EP10743831 A EP 10743831A EP 2415748 A4 EP2415748 A4 EP 2415748A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- novel anti
- inflammatory compounds
- inflammatory
- compounds
- novel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6432—Eicosapentaenoic acids [EPA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6409—Fatty acids
- C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
- C12P7/6434—Docosahexenoic acids [DHA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009037939 | 2009-02-20 | ||
PCT/JP2010/052509 WO2010095706A1 (ja) | 2009-02-20 | 2010-02-19 | 新規抗炎症性化合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2415748A1 EP2415748A1 (de) | 2012-02-08 |
EP2415748A4 true EP2415748A4 (de) | 2013-08-07 |
Family
ID=42633985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10743831.9A Withdrawn EP2415748A4 (de) | 2009-02-20 | 2010-02-19 | Neue entzündungshemmende verbindungen |
Country Status (5)
Country | Link |
---|---|
US (1) | US8853437B2 (de) |
EP (1) | EP2415748A4 (de) |
JP (1) | JP5523439B2 (de) |
TW (1) | TW201039829A (de) |
WO (1) | WO2010095706A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2012026106A1 (ja) * | 2010-08-25 | 2013-10-28 | 国立大学法人 東京大学 | 光学活性な新規抗炎症性化合物及びその製造方法 |
WO2012170791A2 (en) * | 2011-06-10 | 2012-12-13 | The Brigham And Women's Hospital, Inc. | Docosahexaenoyl ethanolamides |
CA2873055C (en) | 2012-05-10 | 2023-10-10 | Solutex Na Llc | Oils with anti-inflammatory activity containing natural specialized proresolving mediators and their precursors |
JP2014136677A (ja) * | 2013-01-15 | 2014-07-28 | Univ Of Tokyo | 早産治療剤 |
GB201301626D0 (en) * | 2013-01-30 | 2013-03-13 | Dignity Sciences Ltd | Composition comprising 15-OHEPA and methods of using the same |
EP2961401B1 (de) | 2013-02-28 | 2019-11-13 | Anida Pharma Inc. | Verfahren zur behandlung von ototoxizität |
AU2014272044B2 (en) * | 2013-05-30 | 2019-11-07 | The Brigham & Women's Hospital Inc. | Novel n-3 immunoresolvents: structures and actions |
EP3267990A4 (de) | 2015-03-10 | 2018-09-05 | ELC Management LLC | Verfahren und zusammensetzungen zur behandlung von haut zur unterdrückung von entzündungen und screening auf wirkstoffe mit stimulation der wege zur unterdrückung von entzündungen |
US20180208536A1 (en) * | 2015-07-20 | 2018-07-26 | The Brigham And Women's Hospital, Inc. | Elucidation of Novel 13-Series Resolvins that Increase with Atorvastatin and Clear Infections |
US10653703B2 (en) | 2015-09-03 | 2020-05-19 | Solutex Na Llc | Compositions comprising omega-3 fatty acids, 17-HDHA and 18-HEPE and methods of using same |
WO2017077528A2 (en) * | 2015-11-02 | 2017-05-11 | Salzman Lovelace Investments, Ltd. | Methods and pharmaceutical compositions for treatment of lung inflammation |
WO2017153977A1 (en) * | 2016-03-08 | 2017-09-14 | Salzman Lovelace Investments, Ltd. | Solid formulations of resolvins and uses thereof |
KR20190127527A (ko) * | 2018-05-04 | 2019-11-13 | 한국생명공학연구원 | 다중불포화지방산의 디-하이드록시 유도체 생산 방법 |
WO2019203540A2 (ko) * | 2018-04-16 | 2019-10-24 | 한국생명공학연구원 | 다중불포화지방산의 멀티-하이드록시 유도체 생산 방법 |
KR102110837B1 (ko) * | 2018-04-16 | 2020-05-14 | 한국생명공학연구원 | 다중불포화지방산의 트리-하이드록시 또는 테트라-하이드록시 유도체 생산 방법 |
KR102673270B1 (ko) * | 2018-10-15 | 2024-06-07 | (주)아모레퍼시픽 | 피부장벽 강화용 조성물 |
KR102144809B1 (ko) * | 2019-10-15 | 2020-08-14 | 한국생명공학연구원 | 신규한 다중불포화지방산의 하이드록시 유도체 및 이의 용도 |
WO2023168245A2 (en) | 2022-03-03 | 2023-09-07 | Thetis Pharmaceuticals Llc | Cyclodextrin complexes of specialized proresolving mediators |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055965A2 (en) * | 2004-11-19 | 2006-05-26 | Martek Biosciences Corporation | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3846801A (en) | 2000-02-16 | 2001-08-27 | Brigham & Womens Hospital | Aspirin-triggered lipid mediators |
WO2003053423A2 (en) | 2001-12-18 | 2003-07-03 | The Brigham And Women's Hospital | Inhibition or prevention of infection by bacteria with epa, dha or analogs |
US7582785B2 (en) | 2002-04-01 | 2009-09-01 | University Of Southern California | Trihydroxy polyunsaturated eicosanoid derivatives |
US7759395B2 (en) | 2002-08-12 | 2010-07-20 | The Brigham And Women's Hospital, Inc. | Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma |
CA2495260C (en) | 2002-08-12 | 2012-05-29 | Brigham And Women's Hospital | Resolvins: biotemplates for novel therapeutic interventions |
US20090318394A1 (en) | 2004-11-19 | 2009-12-24 | Julie Nauroth | Long Chain Polyunsaturated Fatty Acids and Methods of Making and Using the Same |
US20060293288A1 (en) | 2005-01-07 | 2006-12-28 | Serhan Charles N | Use of resolvins to treat gastrointestinal diseases |
AU2007243282A1 (en) | 2006-04-28 | 2007-11-08 | Resolvyx Pharmaceuticals, Inc. | Compositions and methods for the treatment of cardiovascular disease |
JP2009545527A (ja) | 2006-07-19 | 2009-12-24 | リゾルヴィクス・ファーマシューティカルズ・インコーポレイテッド | 粘膜炎の治療用の組成物及び方法 |
WO2008057283A2 (en) | 2006-10-26 | 2008-05-15 | Resolvyx Pharmaceuticals, Inc. | Use of resolvins for inhibition of bone loss |
US20080161275A1 (en) | 2006-12-05 | 2008-07-03 | Resolvyx Pharmaceuticals, Inc. | Compositions and methods for the treatment of inflammatory disease |
US20110190389A1 (en) | 2007-02-20 | 2011-08-04 | Linda Arterburn | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
JP4586051B2 (ja) | 2007-08-03 | 2010-11-24 | 株式会社日立ハイテクノロジーズ | 走査型電子顕微鏡 |
EP2207543A2 (de) | 2007-09-14 | 2010-07-21 | Resolvyx Pharmaceuticals, Inc. | Omega-3-fettsäuren, mehrfach ungesättigte hydroxyfettsäuren, lipoxin-verbindungen oder oxylipin-verbindungen zur behandlung von autoimmunkrankheiten oder zur hemmung der immunfunktion |
JP5421272B2 (ja) | 2007-10-12 | 2014-02-19 | リゾルヴィクス・ファーマシューティカルズ・インコーポレイテッド | 眼病治療のための組成物及び方法 |
-
2010
- 2010-02-19 JP JP2011500656A patent/JP5523439B2/ja not_active Expired - Fee Related
- 2010-02-19 WO PCT/JP2010/052509 patent/WO2010095706A1/ja active Application Filing
- 2010-02-19 US US13/202,489 patent/US8853437B2/en not_active Expired - Fee Related
- 2010-02-19 EP EP10743831.9A patent/EP2415748A4/de not_active Withdrawn
- 2010-02-22 TW TW099105021A patent/TW201039829A/zh unknown
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006055965A2 (en) * | 2004-11-19 | 2006-05-26 | Martek Biosciences Corporation | Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same |
Non-Patent Citations (5)
Title |
---|
HAMPSON A.J. ET AL.: "Biosynthesis of eicosanoids by blood cells of the crab, Carcinus maenas", BIOCHIMICA AND BIOPHYSICA ACTA, vol. 1124, 1992, pages 143 - 150, XP002699600 * |
LEE T.H. ET AL.: "Characterization and biological properties of 5,12-dihydroxy derivatives of eicosapentaenoic acid, including leukotriene B5 and the double lipoxygenae product", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 259, 1984, pages 2383 - 2389, XP002699601 * |
OLIW E H ET AL: "Metabolism of polyunsaturated (n - 3) fatty acids by monkey seminal vesicles: isolation and biosynthesis of omega-3 epoxides", BIOCHIMICA ET BIOPHYSICA ACTA - LIPIDS AND LIPID METABOLISM, ELSEVIER SCIENCE BV. AMSTERDAM, NL, vol. 1086, no. 3, 27 November 1991 (1991-11-27), pages 287 - 294, XP027222690, ISSN: 0005-2760, [retrieved on 19911127] * |
See also references of WO2010095706A1 * |
TAKENAGA M ET AL: "Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid", THROMBOSIS RESEARCH, TARRYTOWN, NY, US, vol. 41, no. 3, 1 February 1986 (1986-02-01), pages 373 - 384, XP026360661, ISSN: 0049-3848, [retrieved on 19860201] * |
Also Published As
Publication number | Publication date |
---|---|
US8853437B2 (en) | 2014-10-07 |
WO2010095706A1 (ja) | 2010-08-26 |
TW201039829A (en) | 2010-11-16 |
JPWO2010095706A1 (ja) | 2012-08-30 |
EP2415748A1 (de) | 2012-02-08 |
JP5523439B2 (ja) | 2014-06-18 |
US20120059061A1 (en) | 2012-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20182200T1 (hr) | Nova protuupalna sredstva | |
EP2415748A4 (de) | Neue entzündungshemmende verbindungen | |
IL215194A0 (en) | Novel anti-inflammatory agents | |
EP2483254A4 (de) | Neue verbindungen | |
GB0905955D0 (en) | Novel compounds | |
EP2512242A4 (de) | Neuartige verbindungen | |
GB0910674D0 (en) | Novel compounds | |
EP2499123A4 (de) | Entzündungshemmende verbindungen | |
GB0910009D0 (en) | Novel compounds | |
GB0901071D0 (en) | Anti-inflammatory compounds | |
GB0907117D0 (en) | Novel compounds | |
GB0906578D0 (en) | Novel compounds | |
GB0907204D0 (en) | Novel compounds | |
GB0907137D0 (en) | Novel compounds | |
GB0907136D0 (en) | Novel compounds | |
GB0907131D0 (en) | Novel compounds | |
GB0907121D0 (en) | Novel compounds | |
GB0907118D0 (en) | Novel compounds | |
GB0908517D0 (en) | Novel compounds | |
GB0907116D0 (en) | Novel compounds | |
GB0907114D0 (en) | Novel compounds | |
GB0907113D0 (en) | Novel compounds | |
GB0907112D0 (en) | Novel compounds | |
GB0907107D0 (en) | Novel compounds | |
GB0907106D0 (en) | Novel compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110819 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20130710 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 29/00 20060101ALI20130628BHEP Ipc: A61P 1/16 20060101ALI20130628BHEP Ipc: A61P 11/06 20060101ALI20130628BHEP Ipc: A61K 31/202 20060101ALI20130628BHEP Ipc: C07C 59/42 20060101AFI20130628BHEP Ipc: A61P 9/10 20060101ALI20130628BHEP Ipc: A61P 1/04 20060101ALI20130628BHEP Ipc: C07C 57/03 20060101ALI20130628BHEP Ipc: A61P 35/00 20060101ALI20130628BHEP Ipc: A61P 43/00 20060101ALI20130628BHEP Ipc: A61P 11/00 20060101ALI20130628BHEP Ipc: A61P 15/08 20060101ALI20130628BHEP Ipc: C12P 7/64 20060101ALI20130628BHEP Ipc: A61P 13/12 20060101ALI20130628BHEP |
|
17Q | First examination report despatched |
Effective date: 20170228 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20180801 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20181212 |